{"DataElement":{"publicId":"62980","version":"3","preferredName":"Bladder Tumor Pathologic T Stage","preferredDefinition":"extent of the primary tumor determined prior to treatment based on evidence obtained from pathological examination of a resected specimen that entails a resection of the primary tumor or biopsy adequate to evaluate the highest category.","longName":"BLAD_TUMOR_P_T_ST","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2190137","version":"1","preferredName":"Bladder Tumor Pathologic T Stage","preferredDefinition":"Information related to the pathologic T stage of a bladder tumor.","longName":"BLAD_TUMOR_P_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206698","version":"1","preferredName":"Bladder Neoplasm","preferredDefinition":"A distensible musculomembranous organ serving as a receptacle for fluid, as the gallbladder.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12414:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bladder","conceptCode":"C12414","definition":"The distensible sac-like organ that functions as a reservoir of urine, collecting from the kidneys and eliminating via the urethra.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-008F-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E6D32761-9F47-2DD0-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-19","modifiedBy":"TAYLORT","dateModified":"2018-11-28","changeDescription":"10/9/17 tt transferred context/BC; added Reg Status.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018484","version":"1","preferredName":"Bladder Tumor Pathologic T Stage","preferredDefinition":"the pathologic T (tumor) stage of a bladder tumor, determined by the AJCC Cancer Staging Manual, 6th Ed.","longName":"BLAD_TUMOR_P_T_ST","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T0","valueDescription":"No evidence of primary tumor","ValueMeaning":{"publicId":"2559524","version":"1","preferredName":"No evidence of primary tumor","longName":"2559524","preferredDefinition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Cancer pT0 TNM Finding v6 and v7","conceptCode":"C60966","definition":"Lung cancer without any evidence of a primary tumor. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B591-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9004-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T1","valueDescription":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","ValueMeaning":{"publicId":"2560341","version":"1","preferredName":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","longName":"2560341","preferredDefinition":"TUMOR INVADES SUBEPITHELIAL CONNECTIVE TISSUE","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9006-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"pT2a","valueDescription":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","ValueMeaning":{"publicId":"2560344","version":"1","preferredName":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","longName":"2560344","preferredDefinition":"TUMOR INVADES SUPERFICIAL MUSCLES (INNER HALF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-9008-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT2b","valueDescription":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","ValueMeaning":{"publicId":"2560335","version":"1","preferredName":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","longName":"2560335","preferredDefinition":"TUMOR INVADES DEEP MUSCLES (OUTER HALF)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-900A-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT3a","valueDescription":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","ValueMeaning":{"publicId":"2560339","version":"1","preferredName":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","longName":"2560339","preferredDefinition":"TUMOR INVADES PERIVESICAL TISSUE MICROSCOPICALLY","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8C0-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E2955C6A-900C-4806-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"pT3b","valueDescription":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","ValueMeaning":{"publicId":"2560338","version":"1","preferredName":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","longName":"2560338","preferredDefinition":"TUMOR INVADES PERIVESICAL TISSUE MACROSCOPICALLY (EXTRAVESICAL MASS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8BF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA12-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4","valueDescription":"Inflammatory Breast Carcinoma","ValueMeaning":{"publicId":"2558969","version":"1","preferredName":"Inflammatory Breast Carcinoma","longName":"2558969","preferredDefinition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Inflammatory Carcinoma","conceptCode":"C4001","definition":"An advanced, invasive breast adenocarcinoma characterized by the presence of distinct changes in the overlying skin. These changes include diffuse erythema, edema, peau d'orange (skin of an orange) appearance, tenderness, induration, warmth, enlargement, and in some cases a palpable mass. The skin changes are the consequence of lymphatic obstruction from the underlying invasive breast adenocarcinoma. Microscopically, the dermal lymphatics show prominent infiltration by malignant cells. The invasive breast adenocarcinoma is usually of ductal, NOS type. There is not significant inflammatory cell infiltrate present, despite the name of this carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B366-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"TAYLORT","dateModified":"2017-07-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA14-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Ta","valueDescription":"NONINVASIVE PAPILLARY CARCINOMA","ValueMeaning":{"publicId":"2559578","version":"1","preferredName":"NONINVASIVE PAPILLARY CARCINOMA","longName":"2559578","preferredDefinition":"NONINVASIVE PAPILLARY CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B5C7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA16-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tis","valueDescription":"CARCINOMA IN SITU: \"FLAT TUMOR\"","ValueMeaning":{"publicId":"2558355","version":"1","preferredName":"CARCINOMA IN SITU: \"FLAT TUMOR\"","longName":"2558355","preferredDefinition":"CARCINOMA IN SITU: \"FLAT TUMOR\"","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B100-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA18-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"Tx","valueDescription":"PRIMARY TUMOR CANNOT BE ASSESSED","ValueMeaning":{"publicId":"2559890","version":"1","preferredName":"PRIMARY TUMOR CANNOT BE ASSESSED","longName":"2559890","preferredDefinition":"PRIMARY TUMOR CANNOT BE ASSESSED","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B6FF-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E295613C-DA1A-47A3-E034-0003BA12F5E7","beginDate":"2002-02-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-08-26","modifiedBy":"SBR","dateModified":"2005-03-29","deletedIndicator":"No"},{"value":"T2","valueDescription":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560359","version":"1","preferredName":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560359","preferredDefinition":"TUMOR MORE THAN 2 CM BUT NOT MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE780675-393D-18EF-E034-0003BA3F9857","beginDate":"2005-08-16","endDate":null,"createdBy":"PWEST","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","deletedIndicator":"No"},{"value":"T3","valueDescription":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","ValueMeaning":{"publicId":"2560360","version":"1","preferredName":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","longName":"2560360","preferredDefinition":"TUMOR MORE THAN 5 CM IN GREATEST DIMENSION","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8D5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FE780675-393F-18EF-E034-0003BA3F9857","beginDate":"2005-08-16","endDate":null,"createdBy":"PWEST","dateCreated":"2005-08-16","modifiedBy":"ONEDATA","dateModified":"2005-08-16","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Tumor invades the prostate, uterus, vagina ","ValueMeaning":{"publicId":"2576653","version":"1","preferredName":"Tumor invades the prostate, uterus, vagina ","longName":"2576653","preferredDefinition":"Tumor invades the prostate, uterus, vagina ","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A86A42-63B3-70F7-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Tumor invades the pelvic wall, abdominal wall","ValueMeaning":{"publicId":"2576654","version":"1","preferredName":"Tumor invades the pelvic wall, abdominal wall","longName":"2576654","preferredDefinition":"Tumor invades the pelvic wall, abdominal wall","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F87B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"CAMPBELB","dateModified":"2005-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"03A86A42-63B7-70F7-E044-0003BA3F9857","beginDate":"2005-10-21","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-21","modifiedBy":"ONEDATA","dateModified":"2005-10-21","deletedIndicator":"No"},{"value":"T4","valueDescription":"T4 Stage Finding","ValueMeaning":{"publicId":"3201437","version":"1","preferredName":"T4 Stage Finding","longName":"3201437","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T4 TNM Finding","conceptCode":"C48732","definition":"A clinical and/or pathologic primary tumor TNM finding indicating direct invasion of adjacent structures by cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9DFFC57B-3E0D-A482-E040-BB89AD433F87","latestVersionIndicator":"Yes","beginDate":"2011-03-08","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-08","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-5199-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"},{"value":"T1/Tis","valueDescription":"T1 Stage Finding Tis Stage Finding","ValueMeaning":{"publicId":"6859386","version":"1","preferredName":"T1 Stage Finding Tis Stage Finding","longName":"6859386","preferredDefinition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.: A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"T1 TNM Finding","conceptCode":"C48720","definition":"A clinical and/or pathologic primary tumor TNM finding indicating that the cancer is limited to the site of growth.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B5A0C1-51A7-6B38-E053-F662850AB3EC","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-51C0-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"},{"value":"Ta/Tis","valueDescription":"Ta Stage Finding Tis Stage Finding","ValueMeaning":{"publicId":"6859387","version":"1","preferredName":"Ta Stage Finding Tis Stage Finding","longName":"6859387","preferredDefinition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.: A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"pTa TNM Finding","conceptCode":"C96025","definition":"A term that refers to a TNM finding of a primary, non-invasive, papillary cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"pTis TNM Finding","conceptCode":"C48738","definition":"A term that refers to a TNM finding of a primary tumor microscopically defined as carcinoma in situ.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"90B5A0C1-51CD-6B38-E053-F662850AB3EC","latestVersionIndicator":"Yes","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"90B5A0C1-51E6-6B38-E053-F662850AB3EC","beginDate":"2019-08-22","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-08-22","modifiedBy":"ONEDATA","dateModified":"2019-08-22","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184339","version":"1","preferredName":"Stage","preferredDefinition":"The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"Stage","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-20A0-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B47181B6-D3C7-304B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"MORENOC","dateModified":"2019-08-22","changeDescription":"added values for T2 & T3 w/o subcategory","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811907","version":"1","longName":"Bladder","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"10000462","version":"1","longName":"Muscle Invasive Blad","context":"CTEP"},{"publicId":"10000312","version":"1","longName":"Superficial Bladder","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811890","version":"1","longName":"Phase III","context":"CTEP"}]}],"AlternateNames":[{"name":"Alliance","type":"USED_BY","context":"Alliance"}],"ReferenceDocuments":[{"name":"COMMENT_348","type":"COMMENT","description":"Note: The AJCC staging version to use is protocol specific.","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"T Stage, Pathologic","url":null,"context":"CTEP"},{"name":"Pathologic T Stage","type":"Preferred Question Text","description":"Pathologic T Stage","url":null,"context":"CTEP"},{"name":"CRF Text1","type":"Alternate Question Text","description":"Pathologic T Stage Results","url":null,"context":"Alliance"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"B4743A8F-3FA2-3430-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-01-17","endDate":null,"createdBy":"MWHITE","dateCreated":"2003-01-17","modifiedBy":"MORENOC","dateModified":"2019-08-22","changeDescription":"ISO 11179 Compliance; added values for T2 & T3 w/o subcategory","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}